Danone North America will invest $65 million over the next two years to increase production of its ready-to-drink coffee brands, including coffee creamer International Delight, oat milk Silk, and cold brew range SToK
A subsidiary of French food and beverage giant Danone, the Colorado-based Danone North America said the investment in its Florida-based factory will enable the company to capitalize on growing consumer demand for RTD coffee and deliver cost savings, efficiencies, and quality improvements.
According to Shane Grant, Group Deputy CEO of Danone North America, the investment will allow them to capitalize on consumer demand in key beverage categories, including coffee creamers, plant-based creamers, and ready-to-drink coffee, in North America, while also supporting their long-term growth agenda.
Danone North America operates 16 production sites and employs 6,000 staff across the US and Canada.


Gold Prices Set for Weekly Loss as Iran Tensions and Fed Rate Outlook Weigh
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
Deutsche Bank Sees Global Capital Shifts Reshaping Long-Term U.S. Dollar Outlook
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
US Stock Futures Steady as Oil Prices Ease, Iran Talks Boost Market Sentiment
Dollar Rises as Middle East Conflict Fuels Inflation and Rate Hike Fears
The American mass exodus to Canada amid Trump 2.0 has yet to materialize
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
European Stocks Slip as Middle East Tensions and Hormuz Threat Rattle Markets
South Korea’s KOSPI Triggers Trading Curb as AI Chip Stock Selloff Deepens
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 



